Jane M. Grant-Kels
CIK: 0002108622
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MANE
Veradermics, Inc
Director
Discretionary Trading P&L
Holdings
About Grant-Kels Jane M.
Grant-Kels Jane M. (SEC CIK 0002108622) files insider reports with the SEC as Director of Veradermics, Inc (MANE).
Signal8 holds 2 ownership filings by Grant-Kels Jane M. (1 Form 3, 1 Form 4), filed between Feb 3, 2026 and Feb 5, 2026. Those filings report 2 transactions, from Feb 3, 2026 to Feb 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Grant-Kels Jane M.'s filings is in NEW HAVEN, CT.
Recent filings by Grant-Kels Jane M.
Other insiders filing for Veradermics, Inc (MANE)
- Hollander David, Chief R&D Officer
- MONTANOVA CAPITAL, LLC, Director
- Durso Timothy August, Chief Technical Officer
- Waldman Reid Alexander, Chief Executive Officer
- CHILDS JOHN W, Director
- Seven Fleet Capital Management LP, 10% Owner